Sobi gains distribution rights for Megace®, Monopril®, Cefzil® and Duricef® from PharmaSwiss

World News: . []

Stockholm Sweden 13 LINK  2013 - Sobi STO Sobi announced that it has entered into a distribution LINK  with PharmaSwiss to market the products LINK  Monopril Cefzil and LINK  approved for the treatment of indications LINK  the on...

More news and information about Swedish Orphan Biovitrum AB (publ)

Published By:

Thomson Reuters: 07:31 GMT Wednesday 13th February 2013

Published: .

Search for other references to "sobi" on SPi News


Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.
Privacy Policy | Terms and Conditions | Contact Us